Greenbaum partner Christopher D. Adams will lecture at the New York & New Jersey Pain Medicine Symposium 2021: Evolving Advanced Pain Therapies, a four-day event that will be hosted by the New York and New Jersey Societies of Interventional Pain Physicians (NYSIPP & NJSIPP) on November 4-7, 2021 at the Hyatt Regency Jersey City.
The NYSIPP & NJSIPP Pain Medicine Symposium was established in 2011 with the primary objectives of educating health care professionals to promote the development of safe, high quality, and cost effective practice of interventional pain management techniques for the diagnosis and treatment of pain and related disorders, and to insure patient access to these interventions.
Mr. Adams will present a session on the “Legal Implications of the Opioid Crisis for Physicians” on Saturday, November 6 from 8:40am – 9:00am.
Mr. Adams is a partner in the firm’s Litigation and Healthcare Departments. As Chair of the Criminal Defense & Regulatory Compliance Practice Group, he concentrates his practice in the areas of criminal defense, internal investigations, attorney ethics matters and disciplinary proceedings, and complex commercial litigation. In the healthcare sector, Mr. Adams has successfully defended physicians charged with crimes in federal and state court, as well as in front of the Board of Medical Examiners (BME). He has negotiated the relicensure of physicians whose licenses were revoked by the BME and assisted in the development of re-entry plans in conjunction with the BME and the Office of the Attorney General. In addition, he has defended physicians in Medicare debarment proceedings and negotiated their re-entry into the Medicare program.
Additional details and registration on the NYSIPP & NJSIPP Symposium’s website.